The trademark application VALMOVIV was filed by Regeneron Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 22, 2020, and it was registered by office on June 30, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).